Webflow Website for Neuroscience Biotech

Webflow build for Annovis Bio, a Phase 3 clinical‑stage biotech developing therapies for Alzheimer’s (AD) and Parkinson’s (PD). The site communicates the mission—restoring nerve cell communication to improve cognitive and motor function—and organizes content for patients, clinicians, and investors: Our Science, Pipeline, Clinical Studies, and Investor Relations with timely news and SEC resources.

Conversion & Narrative UX: Mission‑led hero (“Developing Therapies for Neurodegeneration”), streamlined CTAs to Alzheimer’s, Parkinson’s, Pipeline, and Patient Portal.

Audience Pathways: Role‑based navigation for Patients, Researchers, and Investors; clear “Learn More” flows for AD/PD programs.

Data‑Backed Storytelling: “Growing Challenge” stats modules for AD and PD with scannable figures and sources-ready footers.

Newsroom & IR: CMS‑driven Latest News, Press Releases, media/video libraries, and an IR hub (overview, FAQs, SEC filings, email alerts).

Compliance‑minded Content: Clear disclaimers where needed, accurate labeling of trial phases, and consistent terminology for indications and endpoints.

Contact & Subscriptions: Accessible newsletter signup (with success/error states) and dedicated contact channels (clinical trials, IR, general).

Webflow: Designer, CMS, Interactions 2.0, Symbols/components for global nav/footer.

CMS Collections: News, Press Releases, Publications/Media, Events; templated detail pages with SEO fields.

Performance: WebP imagery, lazy‑loading, minified assets, CDN, responsive typography and grids.

Analytics/SEO: GA4 + GTM, structured meta, Open Graph, sitemap/robots; schema for Organization, NewsArticle where applicable.

Accessibility: Semantic headings, alt text, focus states, keyboard‑navigable menus, reduced‑motion support.

Integrations: Email alerts/newsletter via Webflow forms → CRM/email tool (Zapier/Make); IR links to SEC filings.

Clear patient and investor journeys that reduce friction and increase engagement with AD/PD program content.

Up‑to‑date communications via CMS‑powered news and press, improving credibility with stakeholders.

Polished brand presence with compliant, science‑forward storytelling and disciplined motion design.